Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05790915
Other study ID # HSD 2023 1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2023
Est. completion date March 31, 2024

Study information

Verified date April 2024
Source Hospital Sao Domingos
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Introduction: The SOFA score (Sequential Organ Function Assessment) and its derived measures, such as the Delta SOFA, are used worldwide to determine the severity and prognosis of critically ill patients. Objectives: The primary objective of this study was to assess the impact of standardized interventions on the six organ dysfunctions of SOFA score on outcomes of critically ill patients through the 48-hour delta SOFA with evaluation of the effectiveness of the interventions performed. Result will be correlated with the 28-day mortality. The secondary outcome measures comprised the evaluation of standardized interventions on ICU and hospital length of stay; vasopressor-free and ventilator-free days within the 28 days following ICU admission, through the effectiveness of interventions performed Uni and multivariate statistical analysis will be used to determine organ failures associated to outcome.


Description:

This prospective, observational cohort study will include patients admitted to a medical ICU (12 beds), a surgical ICU (13 beds), and a high complexity surgical and trauma ICU (12 beds). of a tertiary hospital from August 01, 2023 to January31, 2024. The trial will include all patients aged above 18 years, admitted to the ICU for at least 3 days. Patients will be excluded for the following reasons: if they are pregnant, moribund and patients readmitted to the ICU in the same hospital admission. For the patients who met the inclusion criteria, we will collect the demographic data regarding the age, gender, the admission category (medical or surgical), the primary admission diagnosis, the simplified acute physiology score III (SAPS 3), admission sequential organ failure assessment (SOFA) and 48-hour SOFA. Whenever the admission SOFA score is ≥ 2, the result will be presented to the attending physician who will establish in the therapeutic plan the interventions for each of the dysfunctions identified according to a standardized intervention protocol (Table 1). After 48 hours, a new SOFA score is determined, while the prospective clinical surveillance team simultaneously identify if the interventions proposed by the protocol for each of the organ dysfunctions were effectively implemented. Three groups of patients will be identified based on their SOFA scores at admission and the 48-hour delta SOFA values: those with an admission SOFA score < 2 (Group1), those with an admission SOFA score ≥ 2 whose delta SOFA reflected improvement at the end of 48 hours after admission (SOFA after 48 hours < SOFA on admission) (Group 2, n= ) and finally, those with an admission SOFA score ≥ 2 whose SOFA score increased or remained unchanged at the end of 48 hours postadmission (SOFA after 48 hours ≥ admission SOFA) (Group 3, n= ). The effectiveness of the interventions on organic disfunction will be evaluated in the groups 2 and 3 through the formula: Number of patients with an organic disfunction and effective intervention / Number of patients with that organic dysfunction X 100 Results will be correlated with 28-day mortality. Table 1. SOFA standardized protocol 1. Respiratory Protective mechanical ventilation; mechanical power < 16 NIV Prevention of P-SILI: ROX and HACOR index 2. Hemodynamic SOSD protocol; Pressoric target; Lactate clearance 3. Neurologic Image; EEG; Sedation goals 4. Hematologic Basic disease approach; drugs; DDAVP use; platelet transfusion 5. Renal Avoid nephrotoxicity; Avoid hypotension 6. Hepatic Avoid hepatotoxic drugs; basic disease approach. NIV, Non-invasive ventilation; P-SILI, patient self-inflicted lung injury; ROX, ratio of oxygen saturation index; HACOR, Heart rate, acidosis, consciousness oxygenatrion and respiratory rate; SOSD, salvage, optimization, stabilization and de-escalation; DDAVP, 1-desamino-8-d-arginine-vasopresssin.


Recruitment information / eligibility

Status Completed
Enrollment 849
Est. completion date March 31, 2024
Est. primary completion date January 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients aged above 18 years, - Lenght of ICU stay of at least 3 days. Exclusion Criteria: - Pregnant patients - End-of-life - Patients readmitted to the ICU in the same hospitalization

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
Standardized interventions
Standardized interventions according organ dysfunction

Locations

Country Name City State
Brazil Hospital Sao Domingos Sao Luis MA

Sponsors (1)

Lead Sponsor Collaborator
Hospital Sao Domingos

Country where clinical trial is conducted

Brazil, 

References & Publications (8)

Anami EH, Grion CM, Cardoso LT, Kauss IA, Thomazini MC, Zampa HB, Bonametti AM, Matsuo T. Serial evaluation of SOFA score in a Brazilian teaching hospital. Intensive Crit Care Nurs. 2010 Apr;26(2):75-82. doi: 10.1016/j.iccn.2009.10.005. Epub 2009 Dec 29. — View Citation

Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992 Jun;101(6):1481-3. doi: 10.1378/chest.101.6.1481. No abstract available. — View Citation

de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Delta Sequential Organ Failure Assessment. J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.0 — View Citation

de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017 Feb 24;21(1):38. doi: 10.1186/s13054-017 — View Citation

Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009 May;37(5):1649-54. doi: — View Citation

Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. W — View Citation

Soo A, Zuege DJ, Fick GH, Niven DJ, Berthiaume LR, Stelfox HT, Doig CJ. Describing organ dysfunction in the intensive care unit: a cohort study of 20,000 patients. Crit Care. 2019 May 23;23(1):186. doi: 10.1186/s13054-019-2459-9. — View Citation

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Proble — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of standardized interventions in respiratory dysfunction on 48-hour delta SOFA with evaluation of the effectiveness of the interventions performed. Lung protective ventilation: Tidal volume = 6 ml/kg; Plateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100
48 hours
Primary Impact of standardized interventions in hemodinamic dysfunction on 48-hour delta SOFA SOSD (salvage, optimization, stabilization and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamica dysfunction X 100
48 hour
Primary Impact of standardized interventions in neurologic dysfunction on 48-hour delta SOFA Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100
48 hour
Primary Impact of standardized interventions in hematologic dysfunction on 48-hour delta SOFA Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100
48 hour
Primary Impact of standardized interventions iin renal dysfunction on 48-hour delta SOFA Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100
48 hour
Primary Impact of standardized interventions in hepatic dysfunction on 48-hour delta SOFA Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100
48 hour
Secondary Impact of standardized interventions in respiratory dysfunction on ICU length of stay Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100
28 days
Secondary Impact of standardized interventions in hemodinamic dysfuction on ICU length of stay SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100
28 days
Secondary Impact of standardized interventions in neurologic dysfunction on ICU length of stay Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100
28 days
Secondary Impact of standardized interventions in hematologic dysfunction on ICU length of stay Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100
28 days
Secondary Impact of standardized interventions iin renal dysfunction on ICU length of stay Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100
28 days
Secondary Impact of standardized interventions in hepatic dysfunction on ICU length of stay Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100
28 days
Secondary Impact of standardized interventions in respiratory dysfunction on vasopressor-free days Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100
28 days
Secondary Impact of standardized interventions in hemodinamic dysfuction on vasopressor-free days SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100
28 days
Secondary Impact of standardized interventions in neurologic dysfunction on vasopressor-free days Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100
28 days
Secondary Impact of standardized interventions in hematologic dysfunction on vasopressor-free days Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100
28 days
Secondary Impact of standardized interventions iin renal dysfunction on vasopressor-free days Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100
28 days
Secondary Impact of standardized interventions in hepatic dysfunction on vasopressor-free days Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100
28 days
Secondary Impact of standardized interventions in respiratory dysfunction on ventilator-free days Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100
28 days
Secondary Impact of standardized interventions in hemodinamic dysfuction on ventilator-free days SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100
28 days
Secondary Impact of standardized interventions in neurologic dysfunction on ventilator-free days Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100
28 days
Secondary Impact of standardized interventions in hematologic dysfunction on ventilator-free days Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100
28 days
Secondary Impact of standardized interventions iin renal dysfunction on ventilator-free days Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100
28 days
Secondary Impact of standardized interventions in hepatic dysfunction on ventilator-free days Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100
28 days
Secondary Impact of standardized interventions in respiratory dysfunction on hospital length of stay Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure < 28 mmHg; driving pressue < 16 cm H2O; Mechanical power < 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index > 4.8 and HACOR < 5. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with respiratory dysfunction and effective intervention / Number of patients with respiratory dysfunction X 100
60 days
Secondary Impact of standardized interventions in hemodinamic dysfuction on hospital length of stay SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level < 19 mg/dL. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hemodinamic dysfunction and effective intervention / Number of patients with hemodinamic dysfunction X 100
60 days
Secondary Impact of standardized interventions in neurologic dysfunction on hospital length of stay Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1 The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with neurologic dysfunction and effective intervention / Number of patients with neurologic dysfunction X 100
60 days
Secondary Impact of standardized interventions in hematologic dysfunction on hospital length of stay Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated. The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hematologic dysfunction and effective intervention / Number of patients with hematologic dysfunction X 100
60 days
Secondary Impact of standardized interventions in renal dysfunction on hospital length of stay Avoid nephotoxic drugs; Mantain mean arterial blood pressure > 65 mmHg The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with renal dysfunction and effective intervention / Number of patients with renal dysfunction X 100
60 days
Secondary Impact of standardized interventions in hepatic dysfunction on hospital length of stay Avoid hepatotoxic drugs;basic disease approach The effectiveness of the interventions on organic disfunction will be evaluated through the formula:
Number of patients with hepatic dysfunction and effective intervention / Number of patients with hepatic dysfunction X 100
60 days
See also
  Status Clinical Trial Phase
Recruiting NCT04045366 - Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
Completed NCT01411553 - ECG Leadwires: Disposable Versus Cleaned, Reusable N/A
Completed NCT00288743 - Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study Phase 2
Recruiting NCT03529617 - Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates
Not yet recruiting NCT05564975 - Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
Recruiting NCT06234787 - Continuous Subcutaneous Glucose Monitoring in Critical Patients
Completed NCT02198950 - Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
Recruiting NCT01317381 - ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill Phase 4
Completed NCT00470821 - Oral Melatonin in Critically Ill High-risk Patients Phase 4
Completed NCT00460252 - Tight Glycemic Control by eMPC Algorithm in Medical ICU Patients. N/A
Recruiting NCT06049979 - Correlation Between Intestinal Blood Flow and Intestinal Dysfunction in Critically Ill Patients
Active, not recruiting NCT04793568 - Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP Study Phase 2
Recruiting NCT05458687 - Traditional Chinese Medicine for Complications in Critically Ill Patients N/A
Completed NCT01963013 - Non-returning Catheter Valve for Reducing CAUTI N/A
Completed NCT01794468 - A New Monitor to Measure Dermal Blood Flow in Critically Ill Patients: a Preliminary Study N/A
Completed NCT03469882 - High Protein Intake and Early Exercise in Adult Intensive Care Patients N/A
Recruiting NCT04962204 - Virtual Visitation in Intensive Care Unit Study N/A
Completed NCT03205592 - Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients
Recruiting NCT01995565 - Regional Cerebral Hemodynamics Related to Global Hemodynamics N/A
Completed NCT00143494 - The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure N/A